Halliburton Q2: $5.7B Revenue, $0.64 EPS, and Seven Officers Adopt 10b5-1 Plans
HAL sits 64% above its 52-week low of $20.39 on light trading volume (0.3× avg).
Summary
Halliburton posted Q2 2026 revenue of $5.7 billion and EPS of $0.64, while seven officers adopted pre-arranged stock trading plans covering up to 1.75 million shares.
Key Events · Earnings and Guidance · HAL
-
Q2 Revenue and Earnings
Revenue rose 4% to $5.7 billion; net income was $538 million, or $0.64 per share, compared to $480 million and $0.55 a year ago.
-
Seven Officers Adopt 10b5-1 Plans
CEO Jeffrey Miller, CFO Eric Carre, and five other executives adopted pre-arranged trading plans covering up to 1.75 million shares, signaling planned insider selling.
-
IRS Tax Dispute Update
The IRS proposes reclassifying a $3.5 billion deduction from the 2016 Baker Hughes termination fee; an adverse outcome could result in $640 million in cash taxes, though no payment is currently required.
-
Chemical Business Sale Completed
Halliburton completed the sale of a portion of its chemical business in April 2026, recording a $17 million loss on the transaction.
Analysis · HAL · Energy & Transportation
A solid second quarter saw revenue climb 4% to $5.7 billion and net income reach $538 million, powered by international growth even as Middle East disruptions persisted. The period included a $95 million pre-tax credit from investment gains and a government refund. More notably, seven top executives—including the CEO and CFO—adopted Rule 10b5-1 trading plans covering up to 1.75 million shares, a signal of planned selling that could pressure the stock. Meanwhile, the ongoing IRS dispute over a $3.5 billion deduction could result in $640 million in cash taxes if lost, though no payment is currently required. The company also completed the sale of a portion of its chemical business, and geopolitical conflict in the Middle East continues to weigh on operations.
At the time of this filing, HAL was trading at $33.35 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $27.9B. The 52-week trading range was $20.39 to $43.59. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.